Precision BioSciences (DTIL) Misses Q4 EPS by 6c

Precision BioSciences (NASDAQ: DTIL) reported Q4 EPS of ($0.26), $0.06 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $10.59 million versus the consensus estimate of $6.81 million.

For earnings history and earnings-related data on Precision BioSciences (DTIL) click here.

You May Also Be Interested In

• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• Accuray (ARAY) Tops Q4 EPS by 1c
• Lowe's slashes full-year sales outlook amid DIY spending pressure